Sun Pharma falls 6 pct on surprise inspection reports

Reuters Market Eye - Sun Pharmaceutical Industries slumps as much as 6 percent, heading towards its biggest single day fall since March 16, 2012.

*Ranbaxy Laboratories also fell as much as 6 percent.

* Media reports say surprise inspection by U.S. drug regulator on its Halol plant in Gujarat.

* A company spokesman said, "We have no comments to offer".

* "Majority of the inspections taking place nowadays are surprise inspection," Motilal said in a note to its clients.

* Must wait for the final audit report to come, the Motilal note adds.

* Also, Sun Pharma recalled 200 vials of a cancer drug in July.

* Separately, the U.S. FDA said in May that Sun Pharma's response to the import ban on its Karkhadi plant in Gujarat was inadequate.

(Reporting by Abhishek Vishnoi)